Welcome to the New Nuclear Medicine Technologist Section, providing you access to everything you need on the SNMMI website in one place.

The nuclear medicine and molecular imaging technologists are highly specialized healthcare professionals who works closely with the nuclear medicine physician. Some of the technologist’s primary responsibilities are to: Prepare and administer radioactive chemical compounds, known as radiopharmaceuticals and to administer adjunctive medications in order to perform patient imaging procedures using sophisticated instrumentation; Process data and enhance digital images using advanced computer technology; Provide images, data analysis, and patient information to the physician for diagnostic interpretation; and Evaluate new procedures for appropriateness in specific clinical settings and patient populations.

The Society of Nuclear Medicine and Molecular Imaging Technologist Section as part of the SNMMI, is constantly striving to make a difference in the way nuclear medicine and molecular imaging technologists receive academic and continuing education as well as information concerning new procedures, technologies and equipment. Research has been a vital part of SNMMI-TS activities for many years, as has monitoring federal regulation and influencing decisions that affect the practice of nuclear medicine.

In addition to providing discussion forums and publishing journals, newsletters and books, SNMMI-TS also sponsors international meetings and workshops designed to increase the competencies of nuclear medicine practitioners and to promote new scientific advances. The activities of the SNMMI-TS National Council of Representatives, volunteer committee members, and staff focus on improving the quality of care for the patients served by technologists around the world.

Learn more about Nuclear Medicine and Molecular Imaging Technologists.


Continuing Education

SNMMI educational programs are designed to meet the professional development needs of technologists in the field of nuclear medicine and molecular imaging, as well as providing them with continuing education credit opportunities.  SNMMI is an ARRT-recognized conitinuing education mechanism (RCEEMs) provider through the Society's Verification Of Involvement in Continuing Education (VOICE) program.   

SNMMI Educational Programs for Technologists


Professional Advancement

The profession of nuclear medicine and molecular imaging has evolved over the past several years, and continues to evolve to include imaging and therapy beyond the sole use of radioactive materials. Fusion imaging, combining traditional nuclear medicine with other imaging technologies like CT and MRI and their related contrast agents, as well as new and exciting areas like fluorescence imaging are examples of this. ‘Molecular imaging and therapy’ is a phrase which has been developed in recognition of this expansion.  As such, the SNMMI-TS has embraced this evolution with a vision of being the recognized leader in this exciting and ever-growing arena. 

The SNMMI-TS offers several professional advancement opportunities, including the SNMMI-TS Leadership Academy and Porfessional Development Awards and Scholarships. Learn more.

In addition, there are several advanced degree programs and certifications available to the nuclear medicine technologist. Specific areas include; the Nuclear Medicine Advanced Associate (masters degree and certification), PET Certification Exam, CT Certification Exam and NCT Certification Exam. Learn more about these and other opportunities.

Scope of Practice

The spectrum of responsibilities for a nuclear medicine technologist varies widely across the United States. Practice components presented in this document provide a basis for establishing the areas of knowledge and performance for the nuclear medicine technologist. The nuclear medicine technologist must be in compliance with all federal, state, and institutional guidelines, including proper documentation of initial and continued competency in those practices and activities.

Continuing education is a necessary component in maintaining the skills required to perform all duties and tasks of the nuclear medicine technologist in this ever-evolving field.

The Nuclear Medicine Technologist Scope of Practice and Performance Standards document is intended to set forth the standards in important areas of the nuclear medicine technologist’s responsibilities.  It may not cover all areas which may present themselves in actual practice.  These standards do not supersede the judgment of the individual nuclear medicine technologist and other healthcare professionals serving the patient in light of all of the facts of the individual case.  THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING AND THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING TECHNOLOGIST SECTION DISCLAIM ALL LIABILITY ARISING FROM USE OF THESE DOCUMENTS.

NMT Scope of Practice and Performance Standards

Grants and Awards

The SNMMI-TS has a robust grants and awards program sponsored in part by the Education and Research Foundation (ERF). The numerous grants and awards offered spam from financial assistance for tuition for advanced degree programs, travel awards to attend the annual meeting, best abstract awards for abstracts presented during the annual meeting, clinical advancement awards and the leadership academy. 

The SNMMI & SNMMI-TS Grants and Awards Committees are proud to announce that SNMMI has transitioned away from paper and will only be accepting online applications again in 2013!

Click here to learn more about all of the available SNMMI-TS awards and to review past award winners. 

Nuclear Medicine Technologist Career Opportunities

Visit SNMMI's Career Center.

  • April 17, 2014Quantitative Alzheimer’s Imaging Possible with Novel Biomarker

    Typical Alzheimer’s neuroimaging looks at amyloid deposition and neurofibrillary tangles, but a new quantitative method uses arterial input to bring signs of functional disease into sharper relief, according to a study published April 16 in the Journal of Nuclear Medicine .
    (MI: Making a Difference)

  • April 17, 2014Letter to the SNMMI Membership Regarding MAA

    As many of you know, a drastic price increase for macroaggregated albumin (MAA) went into effect on April 1. With all the anger, misstatements and misinformation circulating within the community, I wanted to share with you the SNMMI Board of Directors’ deliberations on this serious issue, as well as discussions we have held with Jubilant Draxlmage (JDI), the sole provider of this product.
    (SNMMI News)

  • April 10, 2014What’s Past Is Prologue: Making The Case For PET Beta-Amyloid Imaging Coverage

    In September of 2013, CMS issued its final decision memo that concluded positron emission tomography- amyloid beta (PET Aß) imaging is “not reasonable or necessary”, finding “insufficient evidence” that use of this diagnostic tool would improve health outcomes for patients with dementia or neurodegenerative disease. As such, PET Aß imaging to help diagnose Alzheimer’s disease (AD) is not a covered service for Medicare beneficiaries except for those enrolled in CMS-approved clinical trials.
    (SNMMI in the News)

  • April 10, 2014PEM Shows Both High Specificity and Sensitivity for Breast Cancer

    Positron emission mammography was found to have 100 sensitivity for all imaged breast tumors, according to a study being presented during the 2014 European Congress of Radiology scientific sessions.
    (MI: Making a Difference)


Just Released! Quick Reference Protocol Manual for Nuclear Medicine Technologists

Protocol_book_cover_2014Targeting technologists specifically, this manual is designed to be a quick reference for technologists to aid in performing the most common nuclear medicine procedures ordered by a referring physician.

Purchase your copy today!